#OST31
LightNews LightNews
cancerletter.com
Immunotherapy for pediatric osteosarcoma with lung metastases after resection shows positive data. Phase IIb clinical trial by OS Therapies Inc.
https://cancerletter.com/clinical-roundup/20250117_8d/
Immunotherapy for pediatric osteosarcoma with lung metastases after resection shows positive data - The Cancer Letter
OS Therapies Inc. announced positive data from a phase IIb clinical trial (NCT04974008) of OST-HER2 (OST31-164)—the company’s HER2-targeted immunotherapy candidate in the rare pediatric-designated indication of prevention of recurrent, fully resected, lung metastatic osteosarcoma. To access this subscriber-only content please log in or subscribe.If your institution has a site license, log in with IP-login or […]
cancerletter.com
January 23, 2025 at 4:00 PM
ke0opr.bsky.social
ICAO: #A34874
Owner: #AIRLINEALANIA
Flt: #OST31 #N310SU #SR20
Time: 2026-07-13 10:28:51 CDT
Min Alt: 3325 ft
Min Dist: 25.8 nm (133deg SE)

#adsb #planefence by kx1t sdr-e adsbexchange flightaware faa
July 13, 2026 at 3:40 PM
ke0opr.bsky.social
ICAO: #A34874
Owner: #AIRLINEALANIA
Flt: #OST31 #N310SU #SR20
Time: 2026-07-07 21:34:16 CDT
Min Alt: 2900 ft
Min Dist: 4.6 nm (53deg NE)

#adsb #planefence by kx1t sdr-e adsbexchange flightaware faa
July 8, 2026 at 2:41 AM
ke0opr.bsky.social
ICAO: #A34874
Owner: #OKLAHOMASTATEUNIVERSITY
Flt: #OST31 #N310SU #SR20
Time: 2026-06-24 15:23:36 CDT
Min Alt: 3450 ft
Min Dist: 25.79 nm (132deg SE)

#adsb #planefence by kx1t sdr-e adsbexchange flightaware faa
June 24, 2026 at 8:35 PM
ke0opr.bsky.social
ICAO: #A34874
Owner: #OKLAHOMASTATEUNIVERSITY
Flt: #OST31 #N310SU #SR20
Time: 2026-06-22 16:11:06 CDT
Min Alt: 3200 ft
Min Dist: 41.8 nm (147deg SSE)

#adsb #planefence by kx1t sdr-e adsbexchange flightaware faa
June 22, 2026 at 9:26 PM
ke0opr.bsky.social
ICAO: #A34874
Owner: #AIRLINEALANIA
Flt: #OST31 #N310SU #SR20
Time: 2026-05-15 10:40:34 CDT
Min Alt: 6225 ft
Min Dist: 49.48 nm (-152deg SSW)

#adsb #planefence by kx1t sdr-e adsbexchange flightaware faa
May 15, 2026 at 3:47 PM
drtimos.bsky.social
Thoughts on this? >> Osteosarcoma Market on the Rise in the 7MM During the
Forecast Period (2025-2034) with Novel Therapeutics and
Technological Innovations | DelveInsight >> Comment below! #industry40 #IoT #mhealth #AI #healthtech
Osteosarcoma Market on the Rise in the 7MM During the Forecast Period (2025-2034) with Novel Therapeutics and Technological Innovations | DelveInsight
The dynamics of the osteosarcoma market are anticipated to change due to the extensive R&D activities, entry of novel potential therapies such as HALMB-0168 (AlaMab Therapeutics in collaboration with CSPC Pharmaceutical), Naxitamab 15-096 (Y-mAbs Therapeutics), OST-HER2 (OST31-154, OS Therapies), and others into the market, and increasing awareness among care providers and givers. LAS VEGAS, July …
dlvr.it
July 30, 2025 at 10:33 PM